1319P Impact of Concomitant Co-Medications on Survival with First-Line Pembrolizumab in 43,000 French Patients with Advanced NSCLC A. Rousseau,S. Foulon, N. Simon-Tillaux,S. Michiels, A. Lolivier,J. Bonastre,D. Planchard,F. Barlesi,J. Remon Masip,P. Lavaud,M. Aldea,M. Frelaut,C. Parisi,C. Le Pechoux,A. Botticella,A. Levy,A. Gazzah,B. BesseAnnals of Oncology（2024）引用 0|浏览5AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
